Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shufeng Zhitong Capsule for Migraine Prevention (Phase III)
CTR20131886Phase 3Completed
- Sponsor
- Beijing Boshili Pharmaceutical Technology
- Start
- Feb 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Shufeng Zhitong Capsule in migraine, sponsored by Beijing Boshili Pharmaceutical Technology. Started Feb 2014; status: completed.
02
Drugs
Shufeng Zhitong Capsule
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20131886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131886.